Global Cancer Monoclonal Antibodies Market 2017-2021

2016-12-27
Price :
Published : Dec-2016
No. of Pages : 115

The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics.

The analysts forecast the global cancer monoclonal antibodies market to grow at a CAGR of 10.86% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global cancer monoclonal antibodies market for 2017-2021. To calculate the market size, This report considers the revenue generated from the sales of branded cancer mAbs and biosimilars used to treat cancer. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

The report, Global Cancer Monoclonal Antibodies Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • F. Hoffmann-La Roche
  • Amgen
  • Bristol-Myers Squibb
  • Takeda Pharmaceuticals

Other prominent vendors

  • AbbVie
  • ADC Therapeutics
  • Agensys
  • Argos Therapeutics
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Biogen
  • Biotech Pharmaceutical
  • BioGenomics
  • Boehringer Ingelheim
  • Celldex Therapeutics
  • Chugai Pharmaceutical
  • CTI BioPharma
  • Daiichi Sankyo
  • Eli Lilly
  • Fortress Biotech
  • Genmab
  • Immunomedics
  • Intas Pharmaceuticals
  • Janssen Biotech
  • Kyowa Hakko Kirin
  • Merck
  • MedImmune
  • Morphotek
  • Neovii Biotech
  • Novartis
  • OncoMed Pharmaceuticals
  • Pfizer
  • Sanofi
  • Seattle Genetics
  • TG Therapeutics
  • Xbiotech

Market driver

  • Increase in demand for ADCs
  • For a full, detailed list, view our report

Market challenge

  • Complicated regulatory framework
  • For a full, detailed list, view our report

Market trend

  • Emergence of targeted and combination therapies
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : Technavio
More Reports
Title Price Buy Now

Fibrosarcoma Global Clinical Trials Review, H2, 2017

Fibrosarcoma Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Fibrosarcoma Global Clinical Trials Review, H2, 2017" provides an overview of Fibrosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Fibrosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical......
$2500

Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H2, 2017

Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H2, 2017" provides an overview of Functional (Non Ulcer) Dyspepsia clinical trials scenario. This report provides top line data relating to the clinical trials on Functional (Non Ulcer) Dyspepsia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using Glob......
$2500

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H2, 2017

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H2, 2017" provides an overview of Gastrointestinal Stromal Tumor (GIST) clinical trials scenario. This report provides top line data relating to the clinical trials on Gastrointestinal Stromal Tumor (GIST). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are ......
$2500

Fibrosis Global Clinical Trials Review, H2, 2017

Fibrosis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Fibrosis Global Clinical Trials Review, H2, 2017" provides an overview of Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Fibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Fungemia Global Clinical Trials Review, H2, 2017

Fungemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Fungemia Global Clinical Trials Review, H2, 2017" provides an overview of Fungemia clinical trials scenario. This report provides top line data relating to the clinical trials on Fungemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Gastroparesis Global Clinical Trials Review, H2, 2017

Gastroparesis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Gastroparesis Global Clinical Trials Review, H2, 2017" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clin......
$2500

Filariasis Global Clinical Trials Review, H2, 2017

Filariasis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Filariasis Global Clinical Trials Review, H2, 2017" provides an overview of Filariasis clinical trials scenario. This report provides top line data relating to the clinical trials on Filariasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials ......
$2500

Gall Stone Global Clinical Trials Review, H2, 2017

Gall Stone Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Gall Stone Global Clinical Trials Review, H2, 2017" provides an overview of Gall Stone clinical trials scenario. This report provides top line data relating to the clinical trials on Gall Stone. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials ......
$2500

Gaucher Disease Global Clinical Trials Review, H2, 2017

Gaucher Disease Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Gaucher Disease Global Clinical Trials Review, H2, 2017" provides an overview of Gaucher Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Gaucher Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials databa......
$2500

Fistula Global Clinical Trials Review, H2, 2017

Fistula Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Fistula Global Clinical Trials Review, H2, 2017" provides an overview of Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated......
$2500